ESTABLISHING A REGIONAL MS MDT IN THE EAST MIDLANDS JONATHAN EVANS - - PowerPoint PPT Presentation

establishing a regional ms mdt in the east midlands
SMART_READER_LITE
LIVE PREVIEW

ESTABLISHING A REGIONAL MS MDT IN THE EAST MIDLANDS JONATHAN EVANS - - PowerPoint PPT Presentation

ESTABLISHING A REGIONAL MS MDT IN THE EAST MIDLANDS JONATHAN EVANS CONSULTANT NEUROLOGIST, QMC NOTTINGHAM: jonathan.evans2@nuh.nhs.uk May 16 th , 2019 NHS England Guidance 9/2018 (Updated 3/2019) Provides a framework to decision-making on MS


slide-1
SLIDE 1

ESTABLISHING A REGIONAL MS MDT IN THE EAST MIDLANDS

JONATHAN EVANS CONSULTANT NEUROLOGIST, QMC NOTTINGHAM: jonathan.evans2@nuh.nhs.uk May 16th, 2019

slide-2
SLIDE 2

NHS England Guidance 9/2018 (Updated 3/2019)

  • Provides a framework to decision-making on MS DMTs
  • Consistent, effective and safe prescribing
  • Takes account of regulatory and commissioning status,

and NICE guidance (http://pathways.nice.org.uk/pathways/multiple-sclerosis)

slide-3
SLIDE 3

Principles of Organisation of MS service for DMTS

  • Every region should make ALL LICENSED MS DRUGS

available.

MS PRESCRIBING SERVICE: ≥1 CONSULTANT NEUROLOGIST WORKING WITH ≥1 MS NURSE

  • All DMT prescribers must participate in regional networks with

requirements for audit, QC and education:

  • DMT prescribing must be delivered by teams, and with

higher-risk DMTs there is a requirement for discussion at an

  • ver-arching MDT meeting
  • Services should be designed to facilitate collection of

mandatory data for audit and governance.

slide-4
SLIDE 4

Stages in Development of MDT:

1.Evaluate Current Practice: Why?

Common to Most Tertiary Centres, we are already running a weekly MS MDT at QMC. However, current arrangements ad hoc:

  • No single pathway for referral
  • Consultants bring their own cases and record discussions individually
  • A centralised record of outcomes is kept, but it is not searchable (rolling, tabulated document

in MS Word)

  • Regional Centres do participate, but no established line for referral: Individual requests to MS

Consultants and MS Coordinator, “Drop-in” discussions etc. As Venue and Time already arranged and agreed, existing structure can be used both as a framework for a new regional MDT, and a forum for discussion of the form this MDT should take Develop a working group for MDT development with a designated lead and work to a Timeline

slide-5
SLIDE 5

Stages in Development of MDT:

  • 2. Determine scope and Identify ‘stakeholders’: Who?

MS Prescribing Service

  • Derby
  • Leicester
  • Lincoln
  • Northampton
  • Kettering
  • Chesterfield

Regional Neuroscience Centre Nottingham QMC

Regional hospitals without MS prescribing service

  • Loughborough
  • Glenfield
  • Boston
  • Grantham
  • Newark
  • Mansfield

Sheffield

(historical links)

slide-6
SLIDE 6

Stages in Development of MDT:

  • 3. Standard Operating Procedure: How?

NHS England specifies minimum requirements for MDT: ≥2 MS Specialist Neurologists ≥1MS Nurse Specialist PLUS Neuroradiology and Pharmacy Expertise NUH Set-Up: “CORE” MDT

  • ≥3/8 MS CONSULTANTS (+Chair)
  • ≥1/3 MS NURSE SPECIALISTS
  • MS CLINIC CO-ORDINATOR

Formalise process: Job planning, Clearly defined roles, Standard Operating Procedure, Attendance Register, Timeline for Audit (Time, Venue already in place) + “NON-CORE”

  • NEURO-RADIOLOGY LINK CONSULTANTS

AND PATHWAY

  • NAMED NEURO-PHARMACIST

Streamline referral process and ensure good governance:

  • Single Point of Access
  • Standard Method of Recording
  • Single Output

As a non-MS Specialist, aim to come up with a system that minimised administrative burden on MS Co-ordinator Develop a proforma for exclusively electronic referrals, and make this “linkable” through Trust intranet in hubs

slide-7
SLIDE 7

UNIVERSAL MS MDT REFERRAL PROFORMA (1)

slide-8
SLIDE 8

UNIVERSAL MS MDT REFERRAL PROFORMA (2)

MDT outcome recorded in “real-time” by Chair Protocol for referring patients for neuroradiology opinion – dovetailing with current NUH system

Completed form is then:

  • 1. Saved in shared access drive as a single permanent record of outcome
  • 2. (Securely) E-mailed back to the source referrer
slide-9
SLIDE 9

Implementation and Feedback

Progress reports delivered at MDT, feedback reviewed and passed to “hubs” for comment Iterative and transparent process MS-MDT “Go-live” date for 5th June 2019 Audit lead to review process at 6 months:

  • Number and distribution of referrals
  • Attendance register/compliance
  • Number of neuroradiology requests

Business case for dedicated Neuro- radiologist?

  • % missing data in referrals
slide-10
SLIDE 10

Summary and Conclusions

Described the stages in developing a fit-for-purpose regional MS MDT Illustrates the importance of a team-working, problem-solving approach in achieving this. Strengths of this approach: ü Utilises existing systems/structures: Achievable ü Single point of access and simplified channels of communication: Good Clinical Governance ü Standardised recording of outcomes: Facilitate clinical audit ü Addresses particular local challenges: Realistic and sustainable Personal Perspective: What is my experience of managing a cohort of MSologists?

slide-11
SLIDE 11

What is my experience of managing a cohort of MSologists?

slide-12
SLIDE 12

Summary and Conclusions

Described the stages in developing a fit-for-purpose regional MS MDT Illustrates the importance of a team-working, problem-solving approach in achieving this. Strengths of this approach: ü Utilises existing systems/structures: Achievable ü Single point of access and simplified channels of communication: Good Clinical Governance ü Standardised recording of outcomes: Facilitate clinical audit ü Addresses particular local challenges: Realistic and sustainable

THANKYOU… …AND QUESTIONS?

jonathan.evans2@nuh.nhs.uk